Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus

被引:3
作者
Chowdhury, Nusrat [1 ]
Kundu, Anup [1 ]
机构
[1] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA
关键词
liposomes; COVID-19; nanoparticle; adjuvant; mRNA vaccine; virus; nanotechnology; advances; IN-WATER EMULSION; SYSTEMIC IMMUNE-RESPONSES; INFLUENZA VACCINE; ISCOMATRIX(TM) ADJUVANT; NANOPARTICLE VACCINES; SILICA NANOPARTICLES; ANTIGEN; DELIVERY; LIPOSOMES; SIZE;
D O I
10.3390/diseases11040177
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The COVID-19 pandemic has had a profound impact on societies, public health, healthcare systems, and the world economy. With over 771 million people infected worldwide and a staggering death toll exceeding 6,960,783 as of 4 October 2023 (according to the World Health Organization), the urgency for a solution was paramount. Since the outbreak, the demand for immediate treatment for COVID-19 viral infection, as well as for effective vaccination against this virus, was soaring, which led scientists, pharmaceutical/biotech companies, government health agencies, etc., to think about a treatment strategy that could control and minimize this outbreak as soon as possible. Vaccination emerged as the most effective strategy to combat this infectious disease. For vaccination strategies, any conventional vaccine approach using attenuated live or inactivated/engineered virus, as well as other approaches, typically requires years of research and assessment. However, the urgency of the situation promoted a faster and more effective approach to vaccine development against COVID-19. The role of nanotechnology in designing, manufacturing, boosting, and delivering vaccines to the host to counter this virus was unquestionably valued and assessed. Several nanoformulations are discussed here in terms of their composition, physical properties, credibility, and applications in past vaccine development (as well as the possibility of using those used in previous applications for the generation of the COVID-19 vaccine). Controlling and eliminating the spread of the virus and preventing future recurrence requires a safe, tolerable, and effective vaccine strategy. In this review, we discuss the potential of nanoformulations as the basis for an effective vaccine strategy against COVID-19.
引用
收藏
页数:19
相关论文
共 120 条
  • [1] Adams S, 2019, ANN ONCOL, V30, P397, DOI [10.1093/annonc/mdy517, 10.1093/annonc/mdy518]
  • [2] The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
    Akinc, Akin
    Maier, Martin A.
    Manoharan, Muthiah
    Fitzgerald, Kevin
    Jayaraman, Muthusamy
    Barros, Scott
    Ansell, Steven
    Du, Xinyao
    Hope, Michael J.
    Madden, Thomas D.
    Mui, Barbara L.
    Semple, Sean C.
    Tam, Ying K.
    Ciufolini, Marco
    Witzigmann, Dominik
    Kulkarni, Jayesh A.
    van der Meel, Roy
    Cullis, Pieter R.
    [J]. NATURE NANOTECHNOLOGY, 2019, 14 (12) : 1084 - 1087
  • [3] LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS
    ALLISON, AC
    GREGORIADIS, G
    [J]. NATURE, 1974, 252 (5480) : 252 - 252
  • [4] Silica Nanoparticle as a Lymph Node Targeting Platform for Vaccine Delivery
    An, Myunggi
    Li, Meng
    Xi, Jingchao
    Liu, Haipeng
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (28) : 23466 - 23475
  • [5] Nanomedicine and the COVID-19 vaccines
    不详
    [J]. NATURE NANOTECHNOLOGY, 2020, 15 (12) : 963 - 963
  • [6] Nanoparticles in the clinic: An update
    Anselmo, Aaron C.
    Mitragotri, Samir
    [J]. BIOENGINEERING & TRANSLATIONAL MEDICINE, 2019, 4 (03)
  • [7] The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen
    Badiee, Ali
    Khamesipour, Ali
    Samiei, Afshin
    Soroush, Dina
    Shargh, Vahid Heravi
    Kheiri, Masoumeh Tavassoti
    Barkhordari, Farzaneh
    Mc Master, W. Robert
    Mahboudi, Fereidoun
    Jaafari, Mahmoud R.
    [J]. EXPERIMENTAL PARASITOLOGY, 2012, 132 (04) : 403 - 409
  • [8] ISCOMs and other saponin based adjuvants
    Barr, IG
    Sjölander, A
    Cox, JC
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 32 (03) : 247 - 271
  • [9] The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination
    Ben Shimon, Marina
    Shapira, Shiran
    Seni, Jonathan
    Arber, Nadir
    [J]. VACCINES, 2022, 10 (07)
  • [10] Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
    Bershteyn, Anna
    Hanson, Melissa C.
    Crespo, Monica P.
    Moon, James J.
    Li, Adrienne V.
    Suh, Heikyung
    Irvine, Darrell J.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 157 (03) : 354 - 365